SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 53.85-4.5%Jan 9 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Metcalf who wrote (5931)3/18/2002 2:48:34 AM
From: Crossy  Read Replies (3) of 52153
 
Mr. Metcalf,
Japan Tobacco's pharma interest was sold in 2000 or 2001 to a company called Nichiiko Pharma, 4541.J, very low Price/Sales ratio.. 0.6.. However their webiste is lacking their pipeline schematics.. Was Japan Tobacco's effort substantial from a scientific point of view ??

On ratings of Japanese firms, they are ULTRA CONSERVATIVE, so I wouldn't use that as an indicator for solidity in a field where historically bankruptcies have been nominal (even in Japan). Almost all Pharmas are earning nicely. Even if Sales are down, costs are down even more, so many jap. pharmas brought bottom line indicators like EBTIDA up, not only from a relative point of view but in absolute amounts also..

rgrds
CROSSY
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News